Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice

DSpace Repository

Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice

Author: Dizdarevic, Sabina; Petersen, Peter Meidahl; Essler, Markus; Versari, Annibale; Bourre, Jean-Cyril; la Fougere, Christian; Valdagni, Riccardo; Paganelli, Giovanni; Ezziddin, Samer; Kalinovsky, Jan; Bayh, Inga; Du, Yong
Tübinger Autor(en):
La Fougère, Christian Jean
Published in: European Journal of Nuclear Medicine and Molecular Imaging (2019), Bd. 46, H. 5, S. 1102-1110
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00259-019-4261-y
ISSN: 1619-7089
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)